Compare Indoco Remedies with FINOLEX IND. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDOCO REMEDIES vs FINOLEX INDUSTRIES - Comparison Results

INDOCO REMEDIES     Change

Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More

FINOLEX INDUSTRIES 
   Change

Established in 1981, Finolex Industries is the only integrated pipe manufacturer in India. It derives 72% of its earnings from the PVC business and the rest from pipes and fittings. The main demand for PVC comes from agricultural, housing, constructi... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    INDOCO REMEDIES FINOLEX INDUSTRIES INDOCO REMEDIES/
FINOLEX INDUSTRIES
 
P/E (TTM) x 135.5 20.3 667.3% View Chart
P/BV x 2.3 2.3 98.4% View Chart
Dividend Yield % 0.6 1.9 31.3%  

Financials

 INDOCO REMEDIES   FINOLEX INDUSTRIES
EQUITY SHARE DATA
    INDOCO REMEDIES
Mar-18
FINOLEX INDUSTRIES
Mar-18
INDOCO REMEDIES/
FINOLEX INDUSTRIES
5-Yr Chart
Click to enlarge
High Rs317756 42.0%   
Low Rs178551 32.3%   
Sales per share (Unadj.) Rs113.1220.6 51.3%  
Earnings per share (Unadj.) Rs4.524.7 18.1%  
Cash flow per share (Unadj.) Rs11.829.6 40.0%  
Dividends per share (Unadj.) Rs1.0010.00 10.0%  
Dividend yield (eoy) %0.41.5 26.4%  
Book value per share (Unadj.) Rs73.2225.2 32.5%  
Shares outstanding (eoy) m92.15124.10 74.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.23.0 74.0%   
Avg P/E ratio x55.526.5 209.5%  
P/CF ratio (eoy) x21.022.1 94.9%  
Price / Book Value ratio x3.42.9 116.5%  
Dividend payout %22.440.5 55.3%   
Avg Mkt Cap Rs m22,83081,118 28.1%   
No. of employees `0005.51.3 423.5%   
Total wages/salary Rs m2,2091,162 190.2%   
Avg. sales/employee Rs Th1,910.121,256.1 9.0%   
Avg. wages/employee Rs Th405.0901.8 44.9%   
Avg. net profit/employee Rs Th75.52,378.3 3.2%   
INCOME DATA
Net Sales Rs m10,41927,378 38.1%  
Other income Rs m47244 19.2%   
Total revenues Rs m10,46627,622 37.9%   
Gross profit Rs m1,3494,839 27.9%  
Depreciation Rs m677606 111.7%   
Interest Rs m23598 239.4%   
Profit before tax Rs m4844,379 11.1%   
Minority Interest Rs m0164 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m721,479 4.9%   
Profit after tax Rs m4123,063 13.4%  
Gross profit margin %12.917.7 73.3%  
Effective tax rate %15.033.8 44.3%   
Net profit margin %4.011.2 35.3%  
BALANCE SHEET DATA
Current assets Rs m5,3738,081 66.5%   
Current liabilities Rs m4,1574,911 84.6%   
Net working cap to sales %11.711.6 100.8%  
Current ratio x1.31.6 78.5%  
Inventory Days Days6882 83.1%  
Debtors Days Days736 1,265.9%  
Net fixed assets Rs m6,2449,746 64.1%   
Share capital Rs m1841,241 14.9%   
"Free" reserves Rs m6,56626,710 24.6%   
Net worth Rs m6,75027,951 24.1%   
Long term debt Rs m1,2330-   
Total assets Rs m12,36335,060 35.3%  
Interest coverage x3.145.6 6.7%   
Debt to equity ratio x0.20-  
Sales to assets ratio x0.80.8 107.9%   
Return on assets %5.29.0 58.0%  
Return on equity %6.111.0 55.6%  
Return on capital %9.016.6 54.3%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3,7620-   
Fx outflow Rs m1,14312,312 9.3%   
Net fx Rs m2,619-12,312 -21.3%   
CASH FLOW
From Operations Rs m1,2273,384 36.3%  
From Investments Rs m-1,360-1,619 84.0%  
From Financial Activity Rs m-388-1,752 22.1%  
Net Cashflow Rs m-52113 -3,974.0%  

Share Holding

Indian Promoters % 59.2 52.5 112.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 12.5 4.6 271.7%  
FIIs % 6.0 4.8 125.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 22.4 38.2 58.6%  
Shareholders   12,805 130,070 9.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare INDOCO REMEDIES With:   TIMKEN INDIA  CENTURY PLYBOARDS  COMPACT DISC  TALWALKARS BETTER VALUE  INDIABULLS FIN. SER.  



Today's Market

Strengthening Rupee, Inflation & Factory Output Data, and Top Stocks in Action Today(Pre-Open)

On Friday, Indian share markets witnessed most of the buying interest during closing hours and ended on a strong note.

Related Views on News

INDOCO REMEDIES Announces Quarterly Results (1QFY20); Net Profit Up 118.1% (Quarterly Result Update)

Aug 14, 2019 | Updated on Aug 14, 2019

For the quarter ended June 2019, INDOCO REMEDIES has posted a net profit of Rs 22 m (up 118.1% YoY). Sales on the other hand came in at Rs 3 bn (up 16.2% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

FINOLEX INDUSTRIES Announces Quarterly Results (1QFY20); Net Profit Down 29.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, FINOLEX INDUSTRIES has posted a net profit of Rs 725 m (down 29.8% YoY). Sales on the other hand came in at Rs 9 bn (up 14.0% YoY). Read on for a complete analysis of FINOLEX INDUSTRIES's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (4QFY19); Net Profit Down 43.3% (Quarterly Result Update)

Jun 6, 2019 | Updated on Jun 6, 2019

For the quarter ended March 2019, INDOCO REMEDIES has posted a net profit of Rs 116 m (down 43.3% YoY). Sales on the other hand came in at Rs 3 bn (down 6.5% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

FINOLEX INDUSTRIES Announces Quarterly Results (4QFY19); Net Profit Down 24.4% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, FINOLEX INDUSTRIES has posted a net profit of Rs 914 m (down 24.4% YoY). Sales on the other hand came in at Rs 10 bn (up 19.2% YoY). Read on for a complete analysis of FINOLEX INDUSTRIES's quarterly results.

FINOLEX INDUSTRIES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 29, 2019 | Updated on Mar 29, 2019

Here's an analysis of the annual report of FINOLEX INDUSTRIES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of FINOLEX INDUSTRIES. Also includes updates on the valuation of FINOLEX INDUSTRIES.

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Insider Buying Alert: Promoters Increase Stake in 8 High-Quality Smallcaps(Profit Hunter)

Sep 3, 2019

Insiders have increased their stakes in eight Hidden Treasure recommendations. Should you follow them?

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

INDOCO REMEDIES SHARE PRICE


Sep 13, 2019 (Close)

TRACK INDOCO REMEDIES

  • Track your investment in INDOCO REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDOCO REMEDIES

INDOCO REMEDIES - WONDERLA HOLIDAYS COMPARISON

COMPARE INDOCO REMEDIES WITH

MARKET STATS